A practical reference on albumin binding: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-06-14. Anything still debated is marked as such rather than presented as settled.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
| Property | Value | Notes |
|---|---|---|
| Molecular formula (free base) | C187H291N45O59 | Approximate; salt and hydrate forms differ |
| Molecular weight | ~4113.6 Da | Varies with counterion and hydration |
| Appearance | White to off-white powder | Lyophilized research material |
| Solubility class | Freely soluble in water | As formulated; native peptide less stable near neutral pH |
| Typical storage | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
肽类的主要降解路径包括天冬酰胺脱酰胺、甲硫氨酸氧化、天冬氨酸异构化以及由 β-折叠驱动的聚集，这些反应对 pH 与缓冲液种类较为敏感。磷酸盐、丙二醇与苯酚等辅料会影响局部微环境与界面行为。强制降解研究借助高温、强光、氧化剂与极端 pH 暴露来预测产物谱。关于长期室温存放的数据相对有限，超出标签条件的稳定性仍属开放问题，需要在具体制剂中通过实时与加速试验加以确认。
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
Certificate of analysis documents from suppliers typically report purity by chromatographic area, water content, and counter-ion identity. Independent verification is advisable because reported values can be generated under differing conditions. Impurity profiles matter for research use, where aggregates, deamidation products, and residual solvents may influence experimental results. Container, lot, and chain-of-custody records support traceability. Analytical results are method-dependent, so comparisons between laboratories require the same procedure and reference standards.
Lyophilized peptide material is typically stored at or below -20 °C, with -80 °C used for longer-term archives. Vials should remain sealed and desiccated because moisture promotes aggregation and hydrolysis. Repeated freeze-thaw cycles are avoided since they can alter peptide conformation and reduce recovery. Once reconstituted, solutions are generally kept at 2-8 °C and used within a defined window. Stability beyond those windows depends on buffer composition and concentration, and exact limits are product-specific rather than universal.
Bromine has two stable isotopes, 79Br and 81Br. These are its only two natural isotopes, with 79Br making up 51% of natural bromine and 81Br making up the remaining 49%. Both have nuclear spin 3/2− and thus may be used for nuclear magnetic resonance, although 81Br is more favourable. The relatively 1:1 distribution of the two isotopes in nature is helpful in identification of bromine containing compounds using mass spectroscopy. Other bromine isotopes are all radioactive, with half-lives too short to occur in nature. Of these, the most important are 80Br (t1/2 = 17.7 min), 80mBr (t1/2 = 4.421 h), and 82Br (t1/2 = 35.28 h), which may be produced from the neutron activation of natural bromine. The most stable bromine radioisotope is 77Br (t1/2 = 57.04 h). The primary decay mode of isotopes lighter than 79Br is electron capture to isotopes of selenium; that of isotopes heavier than 81Br is beta decay to isotopes of krypton; and 80Br may decay by either mode to stable 80Se or 80Kr. Br isotopes from 87Br and heavier undergo beta decay with neutron emission and are of practical importance because they are fission products.
== Chemistry == Lercanidipine is used in form of the hydrochloride, which is a slightly yellow crystalline powder and melts at 197 to 201 °C (387 to 394 °F) in crystal form I or 207 to 211 °C (405 to 412 °F) in crystal form II. It is readily soluble in chloroform and methanol, but practically insoluble in water. This high lipophilicity (compared to older dihydropyridines) is intentional because it causes the substance to bind to lipid membranes, allowing for a longer duration of action. The lercanidipine molecule has one asymmetric carbon atom. While the S-enantiomer is more effective than the R-enantiomer, marketed formulations contain a 1:1 mixture of both (i.e., the racemate).
Normal human hemoglobins are tetrameric proteins composed of two pairs of globin chains, each of which contains one alpha-like (α-like) chain and one beta-like (β-like) chain. Each globin chain is associated with an iron-containing heme molecular component. Throughout life, the synthesis of the alpha-like and the beta-like chains is balanced so that their ratio is relatively constant and there is no excess of either type. The specific alpha and beta-like chains that are incorporated into hemoglobins are highly regulated during development:
This could, in turn, result in increased free concentrations of such drugs and increased effects and/or side effects, potentially necessitating dosage adjustments. Bicalutamide has specifically been found to displace coumarin anticoagulants like warfarin from their plasma binding proteins (namely albumin) in vitro, potentially resulting in an increased anticoagulant effect. This is supported by reports of prolonged prothrombin time and internal bleeding after the introduction of bicalutamide in patients previously stable on coumarin anticoagulants. Close monitoring of prothrombin time and dosage adjustment as necessary is recommended when bicalutamide is used in combination with these drugs. However, in spite of this, no conclusive evidence of an interaction between bicalutamide and other drugs was found in clinical trials of nearly 3,000 patients.
=== Sequence entropy === In bioinformatics, a sequence entropy, also known as sequence complexity or information profile, is a numerical sequence providing a quantitative measure of the local complexity of a DNA sequence, independently of the direction of processing. The manipulations of the information profiles enable the analysis of the sequences using alignment-free techniques, such as for example in motif and rearrangements detection.
Sources: en.wikipedia.org
Heseltine also favoured European cooperation in defence procurement, feeling that this allowed Europe to compete with US firms which receive huge orders from The Pentagon. Crick argues that his experience of Concorde in the early 1970s should have warned him that such multinational ventures are problematic and, because of the political capital invested, hard to cancel when things go wrong. Heseltine played an important role in persuading West German defence minister Manfred Wörner to back the joint Anglo-German-Spanish-Italian Eurofighter, and contrary to the wishes of Thatcher (and previous defence secretary John Nott) who preferred an American or British fighter. Cabinet refused to allow a loosening of the specifications to allow French company Dassault to become involved in the consortium. Agreement was reached at Turin in August 1985. Heseltine also sold 132 Tornados for £4bn to Saudi Arabia later in 1985, accepting oil instead of cash (to the displeasure of Peter Walker, Energy Secretary) so that they would buy British rather than US aircraft. This later formed part of the controversial Al-Yamamah arms deal, the main part of which was signed in 1988.
Among numerous advances in experimental techniques he has developed experimental methods for using DNA microarrays to investigate the basic principles of genome organization. Member Natl. Acad. Sci. USA. Thomas Bruice (1925–2019). American bioorganic chemist at UC Santa Barbara, pioneering researcher in chemical biology. Member Natl. Acad. Sci. USA.
== Medical uses == It is approved by numerous regulatory administrations worldwide, including the US Food and Drug Administration (FDA) (19 October 2009), the European Union's European Medicines Agency (EMA) (14 June 2010), the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) (14 June 2010) and Australia's Therapeutic Goods Administration (TGA) (30 June 2010), for use as a treatment for advanced/metastatic renal cell carcinoma and advanced soft tissue sarcomas. In Australia and New Zealand, it is subsidised under the Pharmaceutical Benefits Scheme (PBS) and by Pharmac respectively, under a number of conditions, including:
==== Off-Target Effects of Gene Knockdown ==== Extensive efforts in computational biology have been directed toward the design of successful dsRNA reagents that maximize gene knockdown but minimize "off-target" effects. Off-target effects arise when an introduced RNA has a base sequence that can pair with and thus reduce the expression of multiple genes. Such problems occur more frequently when the dsRNA contains repetitive sequences. It has been estimated from studying the genomes of humans, C. elegans and S. pombe that about 10% of possible siRNAs have substantial off-target effects. A multitude of software tools have been developed implementing algorithms for the design of general mammal-specific, and virus-specific siRNAs that are automatically checked for possible cross-reactivity. Depending on the organism and experimental system, the exogenous RNA may be a long strand designed to be cleaved by Dicer, or short RNAs designed to serve as siRNA substrates. In most mammalian cells, shorter RNAs are used because long double-stranded RNA molecules induce the mammalian interferon response, a form of innate immunity that reacts nonspecifically to foreign genetic material. Mouse oocytes and cells from early mouse embryos lack this reaction to exogenous dsRNA and are therefore a common model system for studying mammalian gene-knockdown effects.
Unlike plutonium, americium and curium show a very low affinity towards TBP ligand, thus needing further advanced separation processes and different extracting agents such as nitrogen-bearing ligands, also known as soft donors, which have been showing a very good affinity towards actinides. An efficient and selective separation of actinides from lanthanides (Ln) is crucial to meet the Closed Fuel Cycle goal. Lanthanide ions, present in a large mass ratio with respect to actinides in the PUREX raffinate, have a high neutron-capture cross section that would not lead to an efficient minor actinide transmutation. The presence of uranium isotopes and other impurities in the transmutation target could generate further radiotoxic transuranic isotopes by neutron capture, instead of more stable nuclides. Most of the radiotoxic nuclides could be transmuted by thermal neutrons in conventional reactors, but the process would take a lot of time due to the low transmutation efficiency. Recent research is focusing on innovative nuclear transmuters such as Gen IV fast reactors and hybrid reactors (Accelerator-driven Systems). The final product left by the P&T process will be a dense vitrified waste to be disposed of for a smaller period of time. All the benefits coming from the management of nuclear waste by this advanced approach will be a small step towards a sustainable energy source and an increased public acceptance of the nuclear energy.
Sources: en.wikipedia.org
In the canaliculus, secreted hydrogen and chloride ions mix and are secreted into the lumen of the oxyntic gland. The highest concentration that gastric acid reaches in the stomach is 160 mM in the canaliculi. This is about 3 million times that of arterial blood, but almost exactly isotonic with other bodily fluids. The lowest pH of the secreted acid is 0.8, but the acid is diluted in the stomach lumen to a pH of between 1 and 3. There is a small continuous basal secretion of gastric acid between meals of usually less than 10 mEq/hour. There are three phases in the secretion of gastric acid which increase the secretion rate in order to digest a meal:
Ernest O. Lawrence invents the cyclotron. 1934 Josef Mattauch and Richard Herzog develop the double-focusing mass spectrograph. 1936 Arthur J. Dempster develops the spark ionization source. 1937 Aston constructs a mass spectrograph with resolving power of 2000. 1939 Lawrence receives the Nobel Prize in Physics for the cyclotron. 1942 Lawrence develops the Calutron for uranium isotope separation. 1943 Westinghouse markets its mass spectrometer and proclaims it to be "A New Electronic Method for fast, accurate gas analysis". 1946 William Stephens presents the concept of a time-of-flight mass spectrometer. 1953 Wolfgang Paul and Helmut Steinwedel introduce the quadrupole mass filter. 1954 A. J. C. Nicholson (Australia) proposes a hydrogen transfer reaction that will come to be known as the McLafferty rearrangement. 1959 Researchers at Dow Chemical interface a gas chromatograph to a mass spectrometer. 1964 British Mass Spectrometry Society established as first dedicated mass spectrometry society. It holds its first meeting in 1965 in London. 1966 F. H. Field and M. S. B. Munson develop chemical ionization. 1968 Malcolm Dole develops electrospray ionization. 1969 H. D. Beckey develops field desorption. 1974 Comisarow and Marshall develop Fourier Transform Ion Cyclotron Resonance mass spectrometry. 1976 Ronald MacFarlane and co-workers develop plasma desorption mass spectrometry. 1984 John Bennett Fenn and co-workers use electrospray to ionize biomolecules.
== External links == "Real-world Evidence from a Narrow Therapeutic Index Product (Levothyroxine) Reflects the Therapeutic Equivalence of Generic Drug Products". U.S. Food and Drug Administration (FDA). 19 November 2020. Archived from the original on 2 October 2020. Levothyroxine pronunciation guide – audio, phonetic spelling, and syllable breakdown
=== War on cartels (2025–present) === The war on cartels is a hybridization of the war on terror and the war on drugs that describes the most aggressive and militarized phase of US foreign and security policy toward transnational criminal organizations, particularly active beginning in 2025 and into early 2026. Some analysts have noted that this war is moving away from previous paradigms of the war on drugs to become an official war. Unlike the law enforcement–centered efforts of previous decades, this phase is characterized by treating drug cartels not merely as ordinary criminal groups, but as national security threats equivalent to insurgent or terrorist organizations, thereby authorizing the use of high-level military capabilities. As a result, this strategy represents an operational and legal hybridization, as it merges the core objective of the war on drugs—the interdiction of narcotics flows and the dismantling of illicit economies—with the combat doctrine of the war on terror, shifting the paradigm from civilian law enforcement toward military counterinsurgency. By classifying these organizations as existential threats and narcoterrorist entities, the US legitimizes the use of tools traditionally reserved for enemy combatants, such as drone strikes, offensive cyber warfare, and extraterritorial special operations, including Operation Southern Spear, under the premise that cartels are no longer simple criminal groups to be arrested, but rather paramilitary structures that erode state sovereignty and require an asymmetric warfare response to be neutralized.
Dinosaur eggs are the organic vessels in which a dinosaur embryo develops. When the first scientifically documented remains of non-avian dinosaurs were being described in England during the 1820s, it was presumed that dinosaurs had laid eggs because they were reptiles. In 1859, the first scientifically documented dinosaur egg fossils were discovered in France by Jean-Jacques Pouech, although they were mistaken for giant bird eggs (birds were not yet recognized as dinosaurs at the time). The first scientifically recognized non-avian dinosaur egg fossils were discovered in 1923 by an American Museum of Natural History crew in Mongolia. Dinosaur eggshell can be studied in thin section and viewed under a microscope. The interior of a dinosaur egg can be studied using CAT scans or by gradually dissolving away the shell with acid. Sometimes the egg preserves the remains of the developing embryo inside. The oldest known dinosaur eggs and embryos are from Massospondylus, which lived during the Early Jurassic, about 190 million years ago.
Sources: en.wikipedia.org
It is a modified version of the natural hormone, with three amino acid changes and a fatty acid side chain added. These edits extend its half-life from minutes to about one week. The core receptor activity is retained.
Both deliver the same active peptide and act on the same receptor. The tablet includes an absorption enhancer because peptides are poorly taken up intact from the gut. Bioavailability of the oral route is substantially lower, so the two are not dose-equivalent.
No, it is entirely synthetic and does not occur in nature. Native GLP-1 is produced in the gut and pancreas, but the analog is manufactured by chemical synthesis or recombinant methods. Traces of the analog are not expected in people who never received it.
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.